CBD safety check: new study tests supplement in 200 healthy adults
NCT ID NCT06473246
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing the safety of a CBD supplement called VL-SE-01 in 200 healthy adults aged 18 to 55. Participants will take one of four different doses of CBD or a placebo daily for 180 days. The main goal is to check blood markers for kidney, liver, and blood sugar health, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CBD (cannabidiol) isolate and broad extract
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY POPULATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dhanwantri Hospital
RECRUITINGPune, Maharashtra, 411011, India
-
Punawale Hospital
RECRUITINGPune, Maharashtra, 411033, India
-
Shivam Hospital
RECRUITINGDombivali, Maharashtra, 421203, India
-
Shree Ashirwad Hospital
RECRUITINGThane, Maharashtra, 421201, India
-
Vedant Multispeciality Hospital
RECRUITINGPune, Maharashtra, 411019, India
-
Vishwaraj Hospital
RECRUITINGPune, Maharashtra, 412201, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.